Background-Inflammatory bowel diseases (IBD) are characterised by an intens
e infiltration of leucocytes that is mediated by adhesion molecules express
ed on the surface of activated endothelial cells.
Aims-To determine whether drugs used in the treatment of IBD, specifically
dexamethasone (DEX), 5-aminosalicylic acid (5-ASA), methotrexate (MTX), and
6-mercaptopurine (6-MP), alter the expression of endothelial cell adhesion
molecules (ECAMs).
Methods-The expression of P-selectin, E-selectin, intercellular adhesion mo
lecule 1 (ICAM-1), and vascular CAM 1 (VCAM-1) in different vascular beds o
f C57B1/6J mice was measured using the dual radiolabelled monoclonal antibo
dy technique.
Results-Lipopolysaccharide (LPS) elicited a profound increase in the expres
sion of all ECAMs in the mesentery, small intestine, caecum, and distal col
on. The LPS induced increase in CAM expression was not significantly affect
ed by prior treatment with either MTX or 6-MP. However, pretreatment with e
ither DEX or 5-ASA significantly attenuated LPS induced increases in expres
sion of P- and E-selectin, and VCAM-1 in the majority of tissues evaluated.
DEX also blunted the LPS induced increase in ICAM-1 expression in the caec
um and distal colon. DEX, but not 5-ASA, largely abolished the rise in plas
ma tumour necrosis factor alpha elicited by LPS.
Conclusions-These findings suggest that DEX and 5-ASA may exert their benef
icial therapeutic action in IBD, at least in part, by inhibiting the expres
sion of ECAMs which mediate leucocyte adhesion and transmigration in the mi
crovasculature.